These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8775258)

  • 21. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal injuries incidental to irradiation of carcinoma of the cervix of the uterus.
    Schmitz RL; Chao JH; Bartolome JS
    Surg Gynecol Obstet; 1974 Jan; 138(1):29-32. PubMed ID: 4809001
    [No Abstract]   [Full Text] [Related]  

  • 23. Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix.
    Pedersen D; Bentzen SM; Overgaard J
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):941-52. PubMed ID: 8083095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive role of TDF values in late rectal recto-sigmoid complications in irradiation treatment of cervix cancer.
    Deore SM; Viswanathan PS; Shrivastava SK; Supe SJ; Dinshaw KA
    Int J Radiat Oncol Biol Phys; 1992; 24(2):217-21. PubMed ID: 1526858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The severity of late rectal and recto-sigmoid complications related to fraction size in irradiation treatment of carcinoma cervix stage III B.
    Deore SM; Shrivastava SK; Viswanathan PS; Dinshaw KA
    Strahlenther Onkol; 1991 Nov; 167(11):638-42. PubMed ID: 1962277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.
    Ferrigno R; Campos de Oliveira Faria SL; Weltman E; Salvajoli JV; Segreto RA; Pastore A; Nadalin W
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):695-706. PubMed ID: 12573757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix.
    Selke P; Roman TN; Souhami L; Freeman CR; Clark BG; Evans MD; Pla C; Podgorsak EB
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):803-9. PubMed ID: 8244808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of the dose-rate effect of 192Ir source activity on pelvic control and late complications after high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Shiau AC; Yu CY; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    J Radiat Res; 2010; 51(2):173-9. PubMed ID: 20339254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of external beam therapy and three brachytherapy fractions for carcinoma of the uterine cervix.
    Mitsuhashi N; Takahashi M; Nozaki M; Yamakawa M; Takahashi T; Sakurai H; Hayakawa K; Niibe H
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):975-82. PubMed ID: 8083099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
    Roeske JC; Mundt AJ; Halpern H; Sweeney P; Sutton H; Powers C; Rotmensch J; Waggoner S; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):351-8. PubMed ID: 9069307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients.
    Lorvidhaya V; Tonusin A; Changwiwit W; Chitapanarux I; Srisomboon J; Wanwilairat S; Chawapun N; Sukthomya V
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1185-91. PubMed ID: 10725630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers.
    Ota T; Takeshima N; Tabata T; Hasumi K; Takizawa K
    Br J Cancer; 2007 Oct; 97(8):1058-62. PubMed ID: 17895888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of severe urologic complications following radiotherapy for cervical cancer in Japanese women.
    Fujikawa K; Miyamoto T; Ihara Y; Matsui Y; Takeuchi H
    Gynecol Oncol; 2001 Jan; 80(1):21-3. PubMed ID: 11136564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer.
    Ujaimi R; Milosevic M; Fyles A; Beiki-Ardakani A; Carlone M; Jiang H; Lindsay P; Xie J; Gerber R; Croke J; Skliarenko J; Levin W; Han K
    Brachytherapy; 2017; 16(5):968-975.e2. PubMed ID: 28757404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
    Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies.
    Barillot I; Horiot JC; Maingon P; Truc G; Chaplain G; Comte J; Brenier JP
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):189-200. PubMed ID: 10924989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.